Michael S. Rosol
Overview
Michael S. Rosol received an average of $292K in total compensation, including $207K in salary, at Navidea Biopharmaceuticals from 2018 to 2022.
2022Navidea BiopharmaceuticalsChief Medical Officer Principal Executive Officer
2021Navidea BiopharmaceuticalsChief Medical Officer Principal Executive Officer
2020Navidea BiopharmaceuticalsChief Medical Officer
2019Navidea BiopharmaceuticalsChief Medical Officer
2018Navidea BiopharmaceuticalsChief Medical Officer
Source: SEC filings on October 5, 2023, October 24, 2022, August 2, 2021, July 31, 2020, and June 28, 2019.
Related executives
We found 17 more executives who work or worked at Navidea Biopharmaceuticals.
Erika Eves
Navidea Biopharmaceuticals
Vice President, Finance & Administration
Jed Latkin
Navidea Biopharmaceuticals
Chief Executive Officer
Michel Mikhail
Navidea Biopharmaceuticals
Chief Regulatory Officer
Joel Kaufman
Navidea Biopharmaceuticals
Former Chief Business Officer
Michael Goldberg
Navidea Biopharmaceuticals
Chief Executive Officer
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
Thomas Klima
Navidea Biopharmaceuticals
Senior Vice President and Chief Commercial Officer
William Regan
Navidea Biopharmaceuticals
Senior Vice President and Chief Compliance Officer
News
Navidea Biopharmaceuticals Chief Medical Officer Michael Rosol's 2022 pay slips 8% to $430K
October 5, 2023
Navidea Biopharmaceuticals CEO Jed Latkin's 2021 pay rises 10% to $1.3M
October 24, 2022
Navidea Biopharmaceuticals CEO Jed Latkin's 2020 pay jumps 66% to $1.2M
August 2, 2021
Navidea Biopharmaceuticals CEO Jed Latkin's 2019 pay rises 16% to $740K
July 31, 2020
Navidea Biopharmaceuticals CEO Michael Goldberg's 2018 pay jumps 76% to $1.5M
June 28, 2019